{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006040","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.606611+00:00","generated_at":"2026-05-26T23:03:01.176957+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Mangoceuticals announces study on avian flu prevention in poultry using water-based antiviral solution","bullets":["Engaged Vipragen Biosciences for efficacy studies on H5N1 prevention via drinking water solution.","Phase I animal studies showed significant reduction in lung viral load; Phase II ongoing.","Solution uses GRAS ingredients; aims to offer non-pharmaceutical preventive tool.","Avian flu outbreak led to culling of >148M birds in U.S. since 2022; egg prices hit $4.15/dozen Dec 2024.","Global poultry market projected at $375.41B by 2030; company to share final study results upon completion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006040","json":"https://secwatch.observer/filing/0001493152-25-006040.json","markdown":"https://secwatch.observer/filing/0001493152-25-006040.md","text":"https://secwatch.observer/filing/0001493152-25-006040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225006040/0001493152-25-006040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225006040/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:03:01.176957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}